- Companies
- Renishaw
Renishaw Valuation Multiples
Renishaw is valued at $5.5B as of October 2026, a 4.6x revenue multiple. In the last 12 months, Renishaw revenue was $1.1B and Renishaw EBITDA was $268M.
Renishaw Overview
About Renishaw
Renishaw Plc is an engineering company specializing in precision measurement and healthcare technologies. It operates in two reporting segments: Manufacturing technologies, and Analytical instruments and medical devices. Its products include coordinate measuring machines, machine tool probes, metal 3D printers, neurosurgical systems, and dental technologies. The company generates the majority of its revenue from exporting these products to the markets in countries like China, the USA, Japan, and Germany. Renishaw has operations in several countries and focuses on research, development, and manufacturing prominently in the UK, Ireland, and India. The company serves diverse industrial and healthcare sectors.
Founded
1973
HQ
Employees
5.3K
Website
Financials (LTM)
EV
$5.2B
Valuation Multiples
Start free trialRenishaw Financials
Renishaw reported last 12-month revenue of $1.1B and EBITDA of $268M.
In the same LTM period, Renishaw generated $528M in gross profit, $268M in EBITDA, and $184M in net income.
Revenue (LTM)
Renishaw P&L
In the most recent fiscal year, Renishaw reported revenue of $1.1B and EBITDA of $231M.
Renishaw is profitable as of last fiscal year, with gross margin of 46%, EBITDA margin of 21%, and net margin of 15%.
Financial data powered by Morningstar, Inc.
Renishaw Stock Performance
Renishaw has current market cap of $5.5B, and enterprise value of $5.2B.
Market Cap Evolution
Renishaw's stock price is $75.91.
Renishaw share price decreased by 1.1% in the last 30 days, and increased by 63.1% in the last year.
Renishaw has an EPS (earnings per share) of $2.16.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5.2B | $5.5B | 0.0% | -1.1% | 13.6% | 63.1% | $2.16 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRenishaw Valuation Multiples
Renishaw trades at 4.6x EV/Revenue multiple, and 19.2x EV/EBITDA.
EV / Revenue (LTM)
Renishaw Financial Valuation Multiples
As of October 12, 2026, Renishaw has market cap of $5.5B and EV of $5.2B.
Renishaw has a P/E ratio of 30.0x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Renishaw Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Renishaw Margins & Growth Rates
Renishaw grew revenue by 13% and EBITDA by 31% in the last fiscal year.
In the most recent fiscal year, Renishaw reported gross margin of 46%, EBITDA margin of 21%, and net margin of 15%.
Renishaw Margins
Renishaw Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Renishaw Operational KPIs
Renishaw's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Renishaw's Rule of 40 is 37% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Renishaw's Rule of X is 57% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Renishaw Competitors
Renishaw competitors include Minimed Group, Convatec Group, Asahi Intecc, Haemonetics, Novanta, Abbott India, INFICON, Ypsomed, Teleflex and Merit Medical Systems.
Most Renishaw public comparables operate across Test & Measurement, Medical Devices, 3D Printing, DeepTech and HealthTech.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $3.1B | ($33M) | 1.7x | 1.6x | (162.0x) | 10.7x | |||
| $2.4B | $513M | 3.0x | 2.9x | 14.1x | 10.6x | |||
| $919M | $338M | 5.7x | 5.6x | 15.6x | 15.0x | |||
| $1.3B | $268M | 4.8x | 4.6x | 23.7x | 15.4x | |||
| $981M | $153M | 5.0x | 4.5x | 32.1x | 18.6x | |||
| $717M | $198M | 7.7x | 7.3x | 27.8x | 26.3x | |||
| $674M | $126M | 8.2x | 7.2x | 43.9x | 32.3x | |||
| $879M | $392M | 6.8x | 6.8x | 15.3x | 15.4x | |||
This data is available for Pro users. Sign up to see all Renishaw competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by Renishaw
Renishaw has acquired 1 company to date.
Last acquisition by Renishaw was on April 14th 2014. Renishaw acquired Advanced Consulting & Engineering for undisclosed valuation.
Latest Acquisitions by Renishaw
| Description | Advanced Consulting & Engineering is a provider of coordinate measuring machine services including on-site inspections and CAD modeling. From its Lewis Center, Ohio, facility, it supports aerospace, automotive, and medical device industries worldwide with reverse engineering, rapid prototyping, and CMM programming. |
| HQ Country | |
| HQ City | Detroit, MI |
| Deal Date | 14 Apr 2014 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Renishaw acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Renishaw
| When was Renishaw founded? | Renishaw was founded in 1973. |
| Where is Renishaw headquartered? | Renishaw is headquartered in United Kingdom. |
| How many employees does Renishaw have? | As of today, Renishaw has over 5K employees. |
| Who is the CEO of Renishaw? | Renishaw's CEO is William Ernest Lee. |
| Is Renishaw publicly listed? | Yes, Renishaw is a public company listed on London Stock Exchange. |
| What is the stock symbol of Renishaw? | Renishaw trades under RSW ticker. |
| When did Renishaw go public? | Renishaw went public in 1984. |
| Who are competitors of Renishaw? | Renishaw main competitors include Minimed Group, Convatec Group, Asahi Intecc, Haemonetics, Novanta, Abbott India, INFICON, Ypsomed, Teleflex, Merit Medical Systems. |
| What is the current market cap of Renishaw? | Renishaw's current market cap is $5.5B. |
| What is the current revenue of Renishaw? | Renishaw's last 12 months revenue is $1.1B. |
| What is the current revenue growth of Renishaw? | Renishaw revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of Renishaw? | Current revenue multiple of Renishaw is 4.6x. |
| What is the current EBITDA of Renishaw? | Renishaw's last 12 months EBITDA is $268M. |
| What is Renishaw's EBITDA margin? | Renishaw's last 12 months EBITDA margin is 24%. |
| What is the current EV/EBITDA multiple of Renishaw? | Current EBITDA multiple of Renishaw is 19.2x. |
| What is the current FCF of Renishaw? | Renishaw's last 12 months FCF is $112M. |
| What is Renishaw's FCF margin? | Renishaw's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of Renishaw? | Current FCF multiple of Renishaw is 46.0x. |
| How many companies Renishaw has acquired to date? | As of October 2026, Renishaw has acquired 1 company. |
| What was the largest acquisition by Renishaw? | None of the M&A deals Renishaw has completed have disclosed valuations. |
| What companies Renishaw acquired? | Renishaw acquired Advanced Consulting & Engineering. |
| In how many companies Renishaw has invested to date? | Renishaw hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Renishaw
Lists including Renishaw
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




